Statistics
Total Visits
Views | |
---|---|
The glucagon-like peptide 1 receptor agonist exenatide inhibits small intestinal motility, flow, transit, and absorption of glucose in healthy subjects and patients with type 2 diabetes: a randomized controlled trial | 126 |
The glucagon-like peptide 1 receptor agonist exenatide inhibits small intestinal motility, flow, transit, and absorption of glucose in healthy subjects and patients with type 2 diabetes: a randomized controlled trial | 88 |
Total Visits per Month
October 2023 | November 2023 | December 2023 | January 2024 | February 2024 | March 2024 | April 2024 | |
---|---|---|---|---|---|---|---|
The glucagon-like peptide 1 receptor agonist exenatide inhibits small intestinal motility, flow, transit, and absorption of glucose in healthy subjects and patients with type 2 diabetes: a randomized controlled trial | 3 | 9 | 5 | 6 | 15 | 9 | 0 |
File Downloads
Views |
---|
Top Country Views
Views | |
---|---|
United States | 102 |
France | 26 |
China | 20 |
Germany | 12 |
Australia | 11 |
Netherlands | 9 |
Vietnam | 8 |
India | 2 |
Sweden | 2 |
Greece | 1 |
Top City Views
Views | |
---|---|
Ashburn | 36 |
Hanoi | 8 |
Kaleen | 8 |
Rotterdam | 8 |
Fairfield | 7 |
Beijing | 5 |
Cambridge | 5 |
Boardman | 4 |
Dearborn | 3 |
Buffalo | 2 |